References
- Anaya JM, Rodriguez Y, Monsalve DM, et al. A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cucuta, Colombia. J Autoimmun. 2017;77:123–138.
- Congenital Zika syndrome and other birth defects. [ cited 2017 Jun 5]. Available from: https://www.cdc.gov/zika/hc-providers/infants-children/zika-syndrome-birth-defects.html.
- Shan C, Muruato AE, Nunes BTD, et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat Med. 2017;23(6):763–767.
- Zika virus vaccines. [ cited 2017 Feb 6]. Available from: https://www.niaid.nih.gov/diseases-conditions/zika-vaccines.
- Tsetsarkin KA, Kenney H, Chen R, et al. A full-length infectious cDNA clone of Zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development. MBio. 2016;7(4):pii: e01114–e01116.
- Cugola FR, Fernandes IR, Russo FB, et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature. 2016;534(7606):267–271.
- Larocca RA, Abbink P, Peron JP, et al. Vaccine protection against Zika virus from Brazil. Nature. 2016;536(7617):474–478.
- Abbink P, Larocca RA, De La Barrera RA, et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science. 2016;353(6304):1129–1132.
- Kim E, Erdos G, Huang S, et al. Preventative vaccines for Zika virus outbreak: preliminary evaluation. EBioMedicine. 2016;13:315–320.
- Dowd KA, Ko SY, Morabito KM, et al. Rapid development of a DNA vaccine for Zika virus. Science. 2016;354(6309):237–240.
- Richner JM, Himansu S, Dowd KA, et al. Modified mRNA vaccines protect against Zika virus infection. Cell. 2017;168(6):1114–1125.
- Pardi N, Hogan MJ, Pelc RS, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017;543(7644):248–251.
- Zhou B, Meliopoulos VA, Wang W, et al. Reversion of cold-adapted live attenuated influenza vaccine into a pathogenic virus. J Virol. 2016;90(19):8454–8463.
- Beigel JH, Voell J, Huang CY, et al. Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. J Infect Dis. 2009;200(4):501–509.
- Saxena M, Van TT, Baird FJ, et al. Pre-existing immunity against vaccine vectors-friend or foe? Microbiology. 2013;159(Pt 1):1–11.
- WHO/UNICEF Zika virus (ZIKV) vaccine target product profile (TPP): vaccine to protect against congenital Zika syndrome for use during an emergency. [ cited 2017]. Available from: http://www.who.int/immunization/research/development/WHO_UNICEF_Zikavac_TPP_Feb2017.pdf
- Elong NA, Vizcarra EA, Tang WW, et al. Mapping and role of the CD8+ T cell response during primary Zika virus infection in mice. Cell Host Microbe. 2017;21(1):35–46.
- Dejnirattisai W, Supasa P, Wongwiwat W, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat Immunol. 2016;17(9):1102–1108.
- Stettler K, Beltramello M, Espinosa DA, et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016;353(6301):823–826.
- Dengue epidemiology. [ cited 2014 Jun 9]. Available from: https://www.cdc.gov/dengue/epidemiology/index.html.
- World map of areas with risk of Zika. [ cited 2017 Jun 21]. Available from: https://wwwnc.cdc.gov/travel/page/world-map-areas-with-zika.
- Honein MA, Dawson AL, Petersen EE, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA. 2017;317(1):59–68.
- Du L, Tai W, Yang Y, et al. Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines. Nat Commun. 2016;7:13473.
- Testing of investigational inactivated Zika vaccine in humans begins. [ cited 2016 Nov 7]. Available from: https://www.niaid.nih.gov/news-events/testing-investigational-inactivated-zika-vaccine-humans-begins
- Stanley DA, Honko AN, Asiedu C, et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nat Med. 2014;20(10):1126–1129.